Bennicas & Associates, Inc. Eli Lilly & CO Transaction History

Bennicas & Associates, Inc.

$157 Million
Q4 2022

A detailed history of Bennicas & Associates, Inc. transactions in Eli Lilly & CO stock. As of the latest transaction made, Bennicas & Associates, Inc. holds 7,293 shares of LLY stock, worth $5.68 Million. This represents 1.7% of its overall portfolio holdings.

Number of Shares

7,293

Previous 7,293 -0.0%

Holding current value

$5.68 Million

Previous $2.67 Million -0.0%

% of portfolio

1.7%

Previous 1.54%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Jan 12, 2023	SELL	$321.55 - $374.67 $181,354 - $211,313	-564 Reduced 7.18%	7,293 $2.67 Million
Q3 2022 Oct 13, 2022	SELL	$296.48 - $337.87 $21,939 - $25,002	-74 Reduced 0.93%	7,857 $2.54 Million
Q2 2022 Jul 12, 2022	SELL	$278.73 - $327.27 $69,682 - $81,817	-250 Reduced 3.06%	7,931 $2.57 Million
Q1 2022 Apr 15, 2022	SELL	$234.69 - $291.66 $393,809 - $489,405	-1,678 Reduced 17.02%	8,181 $2.34 Million
Q4 2021 Jan 14, 2022	SELL	$224.85 - $279.04 $16,638 - $20,648	-74 Reduced 0.74%	9,859 $2.72 Million
Q3 2021 Oct 08, 2021	SELL	$221.6 - $272.71 $146,034 - $179,715	-659 Reduced 6.22%	9,933 $2.3 Million
Q1 2021 Apr 15, 2021	SELL	$164.32 - $212.72 $81,667 - $105,721	-497 Reduced 4.48%	10,592 $1.98 Million
Q4 2020 Jan 15, 2021	BUY	$130.46 - $172.63 $6,783 - $8,976	52 Added 0.47%	11,089 $1.87 Million
Q3 2020 Oct 15, 2020	SELL	$146.22 - $169.13 $14,329 - $16,574	-98 Reduced 0.88%	11,037 $1.63 Million
Q2 2020 Jul 14, 2020	SELL	$136.42 - $164.18 $79,123 - $95,224	-580 Reduced 4.95%	11,135 $1.83 Million
Q1 2020 Apr 15, 2020	SELL	$119.05 - $147.35 $193,813 - $239,885	-1,628 Reduced 12.2%	11,715 $1.63 Million
Q4 2019 Jan 17, 2020	SELL	$106.92 - $132.43 $113,228 - $140,243	-1,059 Reduced 7.35%	13,343 $1.75 Million
Q3 2019 Oct 07, 2019	BUY	$106.79 - $116.16 $6,087 - $6,621	57 Added 0.4%	14,402 $1.61 Million
Q2 2019 Jul 12, 2019	SELL	$110.79 - $129.32 $32,018 - $37,373	-289 Reduced 1.97%	14,345 $1.59 Million
Q1 2019 Apr 16, 2019	SELL	$111.31 - $131.02 $63,001 - $74,157	-566 Reduced 3.72%	14,634 $1.9 Million
Q4 2018 Jan 18, 2019	SELL	$105.9 - $118.64 $108,547 - $121,606	-1,025 Reduced 6.32%	15,200 $1.76 Million
Q1 2018 Apr 20, 2018	SELL	$74.21 - $87.6 $59,367 - $70,080	-800 Reduced 4.7%	16,225 $1.26 Million
Q4 2017 Jan 24, 2018	SELL	$81.94 - $87.89 $71,697 - $76,903	-875 Reduced 4.89%	17,025 $1.44 Million
Q3 2017 Oct 25, 2017	BUY	$77.07 - $85.54 $1.38 Million - $1.53 Million	17,900	17,900 $1.53 Million

Others Institutions Holding LLY

# of Institutions

4,011

Shares Held

752M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $740B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bennicas & Associates, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Bennicas & Associates, Inc. with notifications on news.

Account

Bennicas & Associates, Inc. Eli Lilly & CO Transaction History